MedPath

Study of the Consequences of Infection on Compliance of Modalities of Decisions of Limitations and Stops of Treatments (COVID-19-LAT)

Conditions
Patient Hospitalized in Intensive Reanimation Unit
Patient Hopsitalized in Internal Medicine Unit
Patient Hospitalized in Disease Infectious Unit
Interventions
Behavioral: decisions of limitations and stop processing
Registration Number
NCT04452487
Lead Sponsor
University Hospital, Clermont-Ferrand
Brief Summary

This survey is performed to examine if during the Covid's crisis, the practitionner's have respected the modalities of the law about the end of life, in particular concerning limitations and stop of therapeutics

Detailed Description

In the current legislativ context notably the Clayes Leonetti law, a very large majority of ICU (Intensive Care Unit) patients die with the establishement of a procedure for the limitation and cessation of therapeutics (LAT). During a viral pandemic, medical resources can be saturated, limiting reflexive abilities in favour of binary decisions. This sorting of patients leads to LAT that could be performed without the elementary modalities stated by the law. Thus, arbitrary medical decisions made alone could expose patients to unjustified " loss of luck ". Increasing the resources mobilized during a pandemic must not make us forget the quality of care provided for the benefit of quantity. In therefore seems legitimate to keep the LAT modalities to ensure our ethical principles. No work in the literature based on actual facts explores the impact of a pandemic on compliance with and maintenance of ethical principles and the legisltaive framework, in particular as regards the procedures of the application of LAT.

The purpose of this study is to assess whether the terms of the LAT are being complied during a pandemic for patients with or without Covid.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2500
Inclusion Criteria
  • Hospitalized major patient
  • Infected or not with Covid-19
  • having a management with a LAT defined by an anticipated or factual restriction of a therapeutic resource ( organ replacement, specific treatment) while his or her state of health requires or may require it, leading or not a death. The patient's death occurs either after a cariac massagewhich corresponds to a maximum management with therapeutic failure or within the framework or in the context of brain death, in these cases there is no LAT ; either without cardiac massage and in this case there is de facto a LAT wether or not it is performed according to legisltaive procedures. All patients who die will beclassified according to this diagram for the inclusion criterion. For surviving patients, an analysis of the record in search of LAT elments will be performed. In the absence of LAT elment in the record, i twill be considered that the patient did not have LAT and therfore will not be included.
Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patient 2019decisions of limitations and stop processingPatients hospitalized in selected centers during march and june 2019
Patient 2020decisions of limitations and stop processingPatients hospitalized in selected centers during march and june 2020 (during COVID-19 pandemia)
Patient 2021decisions of limitations and stop processingPatients hospitalized in selected centers during march and june 2021
Primary Outcome Measures
NameTimeMethod
decisions of limitations and therapeutic stopsat the end of patient's hospitalization, an average of one month

The conformity of the modalities of the decisions of limitations and therapeutic stops will be evaluated by a composite criterion defined by the simultaneous presence of the 3 main modalities imposed by the Clayes-Leonetti law to achieve a limitation that are : An outside consultant's opinion ( required if no advance directives), the caregiver collegial discussion or adherence to patient advance directives, notification of decision in the medical record

Secondary Outcome Measures
NameTimeMethod
Characteristics of the notification of LAT procedureat the end of patient's hospitalization, an average of one month

notification of the decision, the conclusions of the discussions, the opinion of the consultant and the arguments given to justify the LAT

Characteristics of consultant's reasoned opinion for the LAT procedureat the end of patient's hospitalization, an average of one month

formal elements of the consultant's reasoned opinion ( legal term) in the file

gendrer of physiciansDay 0

male or female

Characteristics of physiciansDay 0

professional status

patient's historyday 0

comorbidities

Characteristics of affected organday 0

organ failure

Characteristics of patientsday 0

severity score

COVID-19 patient's statusday 0

COVID19 infection (yes or no)

Exparience of physiciansDay 0

Measured in year of experience

Characteristics of the LAT procedure (persons who participated to the collegial discussion)at the end of patient's hospitalization, an average of one month

number and status of caregivers who participated to the collegial discussion

Characteristics of unitsday 0

number of beds, number of caregivers (medical, paramedical, internal external), number of admissions during periods of study

Age of physiciansDay 0

measured in year

Age of patientsday 0

measured in year

final patient statusday 0

fate

Characteristics of the LAT procedureat the end of patient's hospitalization, an average of one month

formal elements of advance directives

Characteristics of hospitalization's patientsday 0

hospitalization reason

patient's environnementday 0

family presence or relatives

Trial Locations

Locations (3)

Hospices Civiles de Lyon

🇫🇷

Lyon, France

CHU de Clermont-Ferrand

🇫🇷

Clermont-Ferrand, France

CH de Vichy

🇫🇷

Vichy, France

© Copyright 2025. All Rights Reserved by MedPath